Contrast induced nephropathy

Contrast Induced Nephropathy Microchapters
Home
Patient Information
Overview
Definition
Historical Perspective
Pathophysiology
Differentiating Contrast induced nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Contrast induced nephropathy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Contrast induced nephropathy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Contrast induced nephropathy
CDC on Contrast induced nephropathy
Contrast induced nephropathy in the news
Blogs on Contrast induced nephropathy
Directions to Hospitals Treating Contrast induced nephropathy
Risk calculators and risk factors for Contrast induced nephropathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Synonyms and keywords: Contrast agent-associated nephrotoxicity; contrast associated nephrotoxicity; CAN; CIAKI; CIN; contrast-induced acute kidney injury

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:WH Template:WS